Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NS108781
National Institutes of Health
Grant: TL1TR001428
NINDS NIH HHS
Grant: R01 NS108781
NCATS NIH HHS
Grant: UL1 TR001427
National Institutes of Health
Grant: 5TL1TR001428-03
Together: Transforming and Translating Discovery to Improve Health
National Institutes of Health
Grant: 5UL1TR001427-08
Together: Transforming and Translating Discovery to Improve Health
National Institutes of Health
Grant: 5R01NS108781-05
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
FWCI
6.80
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights
Additional file 1 of SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights